SITE009-0098

SITE009 (AUS) › SITE009-0098

SITE009-0098

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE009 (AUS) · Dr. Novak
consented 2025-12-30

enrolled

AEs

2

Serious

0

Dropout signal

–

Adverse events

2

Grade 3 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-02-16 (study day 227); relationship: not assessed

severe assessed

Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-12-21 (study day 170); relationship: RELATED

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.